Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Fasudil |
Synonyms | |
Therapy Description |
Fasudil (HA-1077) is a kinase inhibitor, especially potent against Rho-kinase, preventing downstream signaling and resulting in inhibition of cell proliferation and migration, and induction of apoptosis in cancer cells (PMID: 24908363). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Fasudil | HA-1077|AT 877 | Fasudil (HA-1077) is a kinase inhibitor, especially potent against Rho-kinase, preventing downstream signaling and resulting in inhibition of cell proliferation and migration, and induction of apoptosis in cancer cells (PMID: 24908363). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|